Siemens Fonds Invest GmbH Has $925,000 Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Siemens Fonds Invest GmbH raised its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 282.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,366 shares of the company’s stock after buying an additional 9,870 shares during the quarter. Siemens Fonds Invest GmbH’s holdings in Henry Schein were worth $925,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Venturi Wealth Management LLC raised its position in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC lifted its stake in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares in the last quarter. Allworth Financial LP boosted its holdings in shares of Henry Schein by 180.7% in the fourth quarter. Allworth Financial LP now owns 946 shares of the company’s stock valued at $71,000 after buying an additional 609 shares during the period. Finally, Canada Post Corp Registered Pension Plan bought a new stake in shares of Henry Schein during the fourth quarter worth $95,000. 96.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

HSIC has been the subject of a number of research analyst reports. Barrington Research reduced their target price on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday, May 6th. Piper Sandler reduced their price objective on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research report on Wednesday, April 30th. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Wells Fargo & Company cut their target price on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Finally, StockNews.com cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Henry Schein has an average rating of “Moderate Buy” and an average target price of $79.30.

Insider Buying and Selling at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This represents a 6.05% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company’s stock.

Henry Schein Stock Up 0.7%

HSIC stock opened at $72.05 on Friday. The company has a market cap of $8.77 billion, a price-to-earnings ratio of 29.65, a P/E/G ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The business has a 50 day moving average price of $67.34 and a two-hundred day moving average price of $71.46. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.10 EPS. Analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.